These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27926911)

  • 41. Time discrimination deficits in schizophrenia patients with first-rank (passivity) symptoms.
    Waters F; Jablensky A
    Psychiatry Res; 2009 May; 167(1-2):12-20. PubMed ID: 19339057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Borderline personality disorder and auditory verbal hallucinations.
    Beatson J
    Australas Psychiatry; 2019 Dec; 27(6):548-551. PubMed ID: 31304765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychotic symptoms in frontotemporal dementia: prevalence and review.
    Mendez MF; Shapira JS; Woods RJ; Licht EA; Saul RE
    Dement Geriatr Cogn Disord; 2008; 25(3):206-11. PubMed ID: 18204254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder.
    Rosen C; Grossman LS; Harrow M; Bonner-Jackson A; Faull R
    Compr Psychiatry; 2011; 52(2):126-31. PubMed ID: 21295217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Schneider's first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis.
    Malinowski FR; Tasso BC; Ortiz BB; Higuchi CH; Noto C; Belangero SI; Bressan RA; Gadelha A; Cordeiro Q
    Braz J Psychiatry; 2020; 42(1):22-26. PubMed ID: 31166544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methamphetamine-associated psychosis.
    Grant KM; LeVan TD; Wells SM; Li M; Stoltenberg SF; Gendelman HE; Carlo G; Bevins RA
    J Neuroimmune Pharmacol; 2012 Mar; 7(1):113-39. PubMed ID: 21728034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The special treatment of first rank auditory hallucinations and bizarre delusions in the diagnosis of schizophrenia.
    Shinn AK; Heckers S; Öngür D
    Schizophr Res; 2013 May; 146(1-3):17-21. PubMed ID: 23523693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychopathology of Schizophrenia in South Asia: Has there been a change over the last few decades?
    Sood M; Krishnan V; Chadda RK; K K; Kukreti R
    Asian J Psychiatr; 2019 Jan; 39():80-83. PubMed ID: 30593988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First-rank symptoms of schizophrenia in Schneider-oriented German centers.
    Koehler K; Guth W; Grimm G
    Arch Gen Psychiatry; 1977 Jul; 34(7):810-3. PubMed ID: 327966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Personal account: snapshots: the first symptoms of psychosis.
    Fowler KB
    Schizophr Bull; 2007 Jan; 33(1):16-8. PubMed ID: 16282636
    [No Abstract]   [Full Text] [Related]  

  • 52. Behind the opaque curtain: A 20-year longitudinal study of dissociative and first-rank symptoms in schizophrenia-spectrum psychoses, other psychoses and non-psychotic disorders.
    Humpston C; Harrow M; Rosen C
    Schizophr Res; 2020 Sep; 223():319-326. PubMed ID: 32962885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of impaired reality processing with psychotic symptoms in schizophrenia.
    Lee JS; Chun JW; Lee SH; Kang DI; Kim JJ
    Psychiatry Res; 2013 Dec; 210(3):721-8. PubMed ID: 23992791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duration of untreated psychosis and time to treatment response for delusions and hallucinations.
    Gunduz-Bruce H; McMeniman M; Robinson DG; Woerner MG; Kane JM; Schooler NR; Lieberman JA
    Am J Psychiatry; 2005 Oct; 162(10):1966-9. PubMed ID: 16199847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of the scale for assessment of positive symptoms in Parkinson's disease psychosis.
    Voss TS; Brocht AF; Ravina B
    Mov Disord; 2010 Jan; 25(1):124-5. PubMed ID: 19412941
    [No Abstract]   [Full Text] [Related]  

  • 56. A cross-sectional study of current and lifetime sexual hallucinations and delusions in Lebanese patients with schizophrenia: frequency, characterization, and association with childhood traumatic experiences and disease severity.
    Gerges S; Haddad C; Daoud T; Tarabay C; Kossaify M; Haddad G; Hallit S
    BMC Psychiatry; 2022 May; 22(1):360. PubMed ID: 35624473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between psychotic and obsessive compulsive symptoms in schizophrenia.
    Guillem F; Satterthwaite J; Pampoulova T; Stip E
    Schizophr Res; 2009 Dec; 115(2-3):358-62. PubMed ID: 19560321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis.
    Sato M
    Ann N Y Acad Sci; 1992 Jun; 654():160-70. PubMed ID: 1632581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demographic and clinical characteristics associated with a history of bizarre delusions in a cross-diagnostic sample of individuals with psychotic disorders.
    Yuksel C; Yilmaz S; Nesbit A; Carkaxhiu G; Ravichandran C; Salvatore P; Pingali S; Cohen B; Ongur D
    Asian J Psychiatr; 2018 Jan; 31():82-85. PubMed ID: 29453145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Citalopram-induced hallucinations and delusions in a young adult.
    Capaldi VF; Carr RB
    Gen Hosp Psychiatry; 2010; 32(6):648.e1-3. PubMed ID: 21112465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.